Photo of Winona Tse
Accepting New Patients

Winona Tse, MD

Neurology
Doctor magenta, checkmark badge icon
Mount Sinai Doctors Faculty Practice ?
    • Position
    • ASSOCIATE PROFESSOR | Neurology
    • Specialty
    • Neurology
    • Languages
    • Chinese (Cantonese)
    • English
    • Spanish
    • Hospital Affiliation
    • The Mount Sinai Hospital
    • Phone
    • Bendheim Movement Disorder Center 212-241-5607
    • Mount Sinai Jackson Heights Clinic 718-879-1600

Dr. Tse earned a Bachelor of Arts degree in Biology from the Brown University Program in Liberal Medical Education in 1991, and then graduated with an M.D. degree from SUNY Stony Brook Medical School in 1995. Dr. Tse completed a neurology residency at Mount Sinai Medical Center in 1999, and in the final year served as a Chief Resident. She then completed a fellowship in electromyography at the New York-Cornell Presbyterian Medical Center. She worked at Maimonides Hospital in Brooklyn from 2000 to 2002, where she saw a variety of movement disorders.

As an Associate Professor of Neurology in the Mount Sinai Movement Disorders Center, Dr. Tse sees patients with Parkinson's disease, tremor disorders, dystonia, spasticity and other movement disorders. She has over 15 years of experience in clinical trials in movement disorders. Currently, Dr. Tse is running clinical trials in the movement disorder center in the areas of Parkinson's disease, cervical dystonia, essential tremor and deep brain stimulation for movement disorders.

Dr. Tse is a diplomate of the American Board of Psychiatry and Neurology, and a diplomate of the American Academy of Electrodiagnostic Medicine.

 

Current Clinical Trials in our Movement Disorders Center:

Sublingual apomorphine: An Open-Label, Phase 3 study examining the Long-term safety, tolerability and efficacy of APL- 130277 in levodopa responsive patients wqith Parkinson's disease complicated by motor fluctuations ("OFF" episodes)

A phase 3, Twelve Week, Multicenter, multinational, randomized, double blind, double dummy parallel group study to determine the efficacy, safety, tolerability of P2B001 once daily compared to its individual components in subjects with early Parkinson's disease and to a calibration arm of Pramipexole ER

PROSPECT: Prospective Study for Symptomatic relief of essential tremor with Cala Health

A Phase 3, Randomized, Double Blind, Placebo controlled, parallel group, multicenter trial to evaluate the efficacy and safety of a single treatment of Daxibotulinumtoxin A for injection in adults with isolated cervical dystonia (ASPEN 1)

RESTORE study: To assess sustained effects of droxidopa therapy on patients with symptomatic neurogenic orthostatic hypotension

PSP: A randomized double blind, placebo controlled, parallel group study to evaluate the efficacy and safety of intravenously administered BIIB092 in Participants with Progressive Supranuclear Palsy (closed to enrollment)

PROGRESS: Post MarketClinical Follow up evaluating the Infinity Deep Brain stimulation Implantable Pulse Generator System

 

 

Certifications

Am Board of Electrodiagnostic Medicine
Neurology, American Board of Psychiatry and Neurology

Clinical Focus

Research Topics

Neurology, Neuromodulation, Parkinson's Disease

Education

MD, S.U.N.Y., Stony Brook Sch. of Med

Internship, Internal Medicine
Mount Sinai Hospital

Residency, Neurology
Mount Sinai Hospital

Fellowship, Neuromuscular Dis
Columbia University

Languages

Chinese (Cantonese), English, Spanish